Order of the Court (Eighth Chamber) of 2 March 2017 (request for a preliminary ruling from the Nejvyšší soud — Czech Republic) — Criminal proceedings against Juraj Sokáč

(Case C-497/16) (1)

((Reference for a preliminary ruling - Article 99 of the Rules of Procedure of the Court of Justice - Drug precursors - Regulation (EC) No 273/2004 - Article 2(a) - Definition of ‘scheduled substance’ - Exclusion of medicinal products - Directive 2001/83/EC - Article 1(2) - Definition of ‘medicinal product’ - Medicinal product containing ephedrine or pseudoephedrine - Regulation (EC) No 111/2005 - Article 2(a) - Definition of ‘scheduled substance’ - Annex - Inclusion of medicinal products containing ephedrine or pseudoephedrine - No effect on the scope of Regulation (EC) No 273/2004))

(2017/C 168/23)

Language of the case: Czech

Referring court

Nejvyšší soud

Party to the criminal proceedings in the main proceedings

Juraj Sokáč

Operative part of the order

‘Medicinal products’, within the meaning of Article 1(2) of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, as amended by Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, which contain ‘scheduled substances’, within the meaning of Article 2(a) of Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February 2004 on drug precursors, as amended by Regulation (EU) No 1258/2013 of the European Parliament and of the Council of 20 November 2013, such as ephedrine and pseudoephedrine, remain excluded from the scope of Regulation No 273/2004 following the entry into force of Regulation No 1258/2013 and Regulation (EU) No 1259/2013 of the European Parliament and of the Council of 20 November 2013 amending Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Union and third countries in drug precursors.

(1)  OJ C 22, 23.1.2017.